Search Results
Dec 02, 2025, 12:00 ET Prowler Introduces Attack Path Visualization, Turning Cloud Complexity into Clear, Actionable Risk Paths
Dec. 2, 2025 /PRNewswire/ -- Prowler, the leader in open cloud security, today announced the release of Attack Path Visualization, a major enhancement to the Prowler platform that reveals how threats move across multi-cloud environments and identifies the most
More news about: Prowler
Dec 02, 2025, 12:00 ET New Josh Bersin Company Data Spotlight: CHROs Now Face Complex and Difficult Realities
business background (e.g., consulting, strategy, or commercial roles), potentially widening the gap between what's needed and the typical CHRO development path. The study found this cohort outperforms their peers, but how can a CHRO get real leadership experience?The Aspiration ParadoxMany
More news about: The Josh Bersin Company
Dec 02, 2025, 11:00 ET Harness Announces New Integrations with AWS to Connect AI Software Development with Intelligent Delivery
solving this by bringing together the trusted and secure AI developer solutions from AWS and Harness's delivery intelligence to create a continuous path from code creation to deployment. These efforts redefine what it means to build and release software in the AI era — turning the once-separate steps
More news about: Harness
Dec 02, 2025, 11:00 ET Zerve, the Agentic Data Workspace, Launches Its Notebook
WorkNotebooks became - and stayed - popular, because they make data exploration simple: try an idea, see results instantly, and follow a clear path of reasoning. But as data work has evolved, traditional notebooks have not kept pace. Local environments break. Hidden global state leads to inconsistent
More news about: Zerve
Dec 02, 2025, 10:45 ET Databahn Brings Unified IT and Security Data Pipelines to AWS Marketplace
creation, validation, and transformation workflows.AWS customers will now have access to Databahn through AWS Marketplace, giving them a faster path to AI-optimized security data pipelines directly within their existing AWS billing and procurement workflows. This allows teams to ingest, optimize,
More news about: DataBahn
Dec 02, 2025, 10:30 ET AOB Pharma receives European Medicines Agency (EMA) positive decision on the pediatric investigation plan (PIP), supporting future development of B244 for the treatment of mild to moderate atopic dermatitis in children, adolescents, and adults in the European Union (EU)
Committee (PDCO) agrees to AOBiome's PIP with a positive decision on September 10, 2025 and publishes in the EMA website on November 06, 2025, paving the path for development of B244 in the EU.PDCO decision includes granting a topical corticosteroid (TCS) comparator waiver in Europe for AOBiome's
More news about: AOBiome Therapeutics
Dec 02, 2025, 10:18 ET Cellipont Bioservices Expands Manufacturing Capabilities with New Ballroom-style Cleanroom and 50-liter Single-use Bioreactor to Advance Cell Therapy Production
development to large-scale, commercial manufacturing. This system enhances batch consistency, process scalability, and production efficiency, accelerating the path from clinical development to commercialization for allogeneic therapies.Key Benefits for Cell Therapy InnovatorsTrue
More news about: Cellipont Bioservices
Dec 02, 2025, 10:07 ET PARWCC Launches First-of-Its-Kind Interview Coaching Bundle as Algorithmic Hiring Rapidly Reshapes Job Interviews
help clients manage both the emotional demands of interviewing and the technical demands of AI-driven assessments. This bundle is the first training path that addresses all three."A Full-Spectrum Approach for a Transformed Hiring MarketThe
More news about: Professional Association of Resume Writers and Career Coaches
Dec 02, 2025, 10:00 ET Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
strengthen every part of our mission. His arrival positions PICI to expand our scientific and venture portfolios, enrich partnerships, and speed the path toward making more cancers curable."Veich previously served as Vice Provost for External Affairs at Weill Cornell Medicine and as Managing Director
More news about: Parker Institute for Cancer Immunotherapy
Dec 02, 2025, 09:45 ET EHS Announces Intent to Nominate Directors at Upcoming TrueBlue Annual Meeting
"TrueBlue remains on the wrong path as operational performance continues to deteriorate and the share price approaches all-time lows. Meaningful change at the Board level is now necessary,"
More news about: EHS Investments
Dec 02, 2025, 09:30 ET Purina and RedRover Announce 2025 Purple Leash Project Grants, Advancing Pet-Friendly Domestic Violence Sheltering Nationwide
not being able to bring their pets with them," said Katie Campbell, President and CEO of RedRover. "When shelters can welcome pets, survivors gain a path to safety that doesn't force them to leave behind the companion who has provided comfort, protection and unconditional love. These grants are helping
More news about: Purina
Dec 02, 2025, 09:18 ET A Novel Drug-Free Approach to Reverse Our Mental Health Crisis
Singh, CEO and Founder of MindFit®, was diagnosed with anxiety disorder at age 15, doctors rushed to prescribe him a benzodiazepine, without providing a path to independence."I train my body to be fit and healthy. Why isn't there a way to build "mental fitness"? I never want to depend
More news about: MindFit®
Dec 02, 2025, 09:01 ET Cresta Automation Discovery Provides a Blueprint for Where and How to Deploy AI Agents
with AI Agents.Automation Discovery includes:Conversation Flow Mapping: Cresta automatically maps the "happy path" of a conversation, and highlights common deviations, phases, entry/exit conditions, and branching points. This gives a clear picture of flow structure
More news about: Cresta
Dec 02, 2025, 09:00 ET Next Pathway Achieves Snowflake's Highest Partner Status
TESTER, automates the end-to-end path to a successful cloud migration.
More news about: Next Pathway
Dec 02, 2025, 09:00 ET Next Pathway Achieves Snowflake's Highest Partner Status
TESTER, automates the end-to-end path to a successful cloud migration.Media Contact: Mandi Scott, [email protected]
More news about: Next Pathway
Dec 02, 2025, 09:00 ET Shareholders that lost money on aTyr Pharma, Inc.(ATYR) should contact Levi & Korsinsky about pending Class Action - ATYR
from baseline in mean daily OSC dose at week 48. Additionally, aTyr announced that the Company's next step was to engage with the FDA to determine a path forward, given the disappointing topline results. Following this news, the price of aTyr's common stock declined from a closing market price of $6.03
More news about: Levi & Korsinsky, LLP
Dec 02, 2025, 09:00 ET MKB Announces Closing of its Third Energy Transition Fund
The firm focuses on scalable, high-impact themes at the core of the transition, partnering with those that demonstrate strong fundamentals and a clear path to scale. MKB's experienced team brings deep sector expertise and a disciplined investment approach to support companies driving the decarbonization
More news about: MKB
Dec 02, 2025, 09:00 ET Credent Wealth Management Expands Partnership with Crestline Investors to Support Next Phase of Growth
partnership with a firm that we believe is well-positioned to support advisors in their mission, offering transparent economics, independence, and a clear path to ownership and succession."Ardea Partners LP acted as the exclusive financial advisor to Credent.Firms interested in exploring partnership
More news about: Credent Wealth Management
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
deliver clinically meaningful improvements in bleeding for patients with HHT. These findings provide encouraging signs that we may be on a promising path toward a much-needed treatment option for this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed
More news about: Vaderis Therapeutics AG
Dec 02, 2025, 09:00 ET Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy's Potential for Patients with Hereditary Hemorrhagic Telangiectasia
deliver clinically meaningful improvements in bleeding for patients with HHT. These findings provide encouraging signs that we may be on a promising path toward a much-needed treatment option for this community, which remains without approved therapies," said Hanny Al-Samkari, MD, The Peggy S. Blitz Endowed
More news about: Vaderis Therapeutics AG
Dec 02, 2025, 09:00 ET Maven Clinic and 4Kira4Moms Announce Fourth Cohort of MPact for Families Fellows
happen!""Families in the United States deserve a safer, more affordable maternal health system" said Dr. Neel Shah, Chief Medical Officer of Maven Clinic. "And the path to safer births in America runs through our communities. Those closest to the challenge have always held the wisdom to solve it — and our role is to
More news about: Maven Clinic
Dec 02, 2025, 09:00 ET Aidoc Unlocks the Last Mile for Homegrown Imaging AI
API. MONAI is the world's leading open-source framework for medical imaging AI, with nearly 500,000 downloads per month. This creates a standardized path from development to real clinical workflows without each organization rebuilding infrastructure, monitoring, security or integrations from scratch[1].NVIDIA
More news about: Aidoc
Dec 02, 2025, 08:54 ET Alkemi Introduces Secure Way for Companies to Sell Data into the $4.4T AI Economy
model, yet many struggle to showcase its value or move prospects through slow, technical evaluations. DataLab gives providers a faster, safer path to revenue and a way to distribute their data directly into the fast-growing AI economy (estimated at $4.4 trillion, per
More news about: Alkemi
Dec 02, 2025, 08:50 ET Scinai Reports Nine-Month 2025 Results as CDMO Growth Continues and NanoAbs Pipeline Advances
currently reviewing the program's forward path and evaluating several alternatives. These include, among other options, submitting a new non-dilutive grant application in early 2026 or potentially terminating Scinai's option to acquire Pincell if a viable financing path cannot be secured.Scinai currently
More news about: Scinai Immunotherapeutics Ltd.
Dec 02, 2025, 08:45 ET Molex Names Top 10 Connectivity and Electronics Design Predictions for 2026, Fueled by Far-Reaching Impact of Artificial Intelligences Across Major Industries
solutions designed for 224Gbps PAM-4 speed, along with high-speed pluggable I/O connectors that support aggregate speeds up to 400/800Gbps while providing a path to 1.6T.Energy consumption hampers data-center scaling, propelling advancements in thermal management The
More news about: Molex Incorporated